Apellis Pharmaceuticals Inc (APLS)
47.46
-0.03
(-0.06%)
USD |
NASDAQ |
May 03, 16:00
46.01
-1.45
(-3.06%)
After-Hours: 20:00
Apellis Pharmaceuticals Total Long Term Debt (Quarterly): 93.03M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 93.03M |
September 30, 2023 | 92.96M |
June 30, 2023 | 92.88M |
March 31, 2023 | 92.81M |
December 31, 2022 | 92.74M |
September 30, 2022 | 92.66M |
June 30, 2022 | 189.31M |
Date | Value |
---|---|
March 31, 2022 | 189.17M |
December 31, 2021 | 189.02M |
September 30, 2021 | 189.61M |
June 30, 2021 | 386.47M |
March 31, 2021 | 386.15M |
December 31, 2020 | 358.83M |
September 30, 2020 | 353.77M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
92.66M
Minimum
Sep 2022
386.47M
Maximum
Jun 2021
199.96M
Average
189.10M
Median
Total Long Term Debt (Quarterly) Benchmarks
Blueprint Medicines Corp | 238.81M |
Sarepta Therapeutics Inc | 1.239B |
Alnylam Pharmaceuticals Inc | 1.022B |
Ionis Pharmaceuticals Inc | 1.283B |
Madrigal Pharmaceuticals Inc | -- |